13 min listen
ACCEL Lite: STRENGTH Trial: High-Dose Omega-3 Fatty Acids vs. Corn Oil
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: STRENGTH Trial: High-Dose Omega-3 Fatty Acids vs. Corn Oil
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
11 minutes
Released:
Apr 20, 2021
Format:
Podcast episode
Description
The benefits and risks of fish oil derivatives remain controversial. STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) showed no benefits from administration of high doses of a carboxylic formulation containing both eicosapentaenoic acid and docosahexaenoic acid, but it did show an increase in risk of atrial fibrillation. In this interview, Steven E. Nissen MD, MACC; Stephen J. Nicholls MBBS, PhD, FACC; and Michael Mikolaj MD, MPH, FACC, discuss STRENGTH and whether omega-3 fatty acids produce net benefit or harm. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at www.ACC.org/ACCEL.
Released:
Apr 20, 2021
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: Low-Flow, Low-Gradient AS: When Is it Severe?: Severe aortic stenosis may go unrecognized, and therefore untreated, in the setting of a low gradient, even if all data point to the existence of a low-flow, low-gradient state and a severe degree of stenosis. In this interview, Mirvat Alasnag, MB,... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research